In New Ad Campaign, NACDS Calls on U.S. Congress to Pass “REAL REFORM” to Stop PBM Tactics Threatening Americans and Pharmacies
Pharmacists to Lawmakers: “If all patients don't benefit … it's not real reform.”
Pharmacists to Lawmakers: “If all patients don't benefit … it's not real reform.”
See Jeff Woldt’s May 22 article in Mass Market Retailers — “Time is right for NACDS to once again 'deliver’” — which describes well NACDS’ pro-patient, pro-pharmacy policy priorities.
Statement defines specific solutions for patient-manipulation by “PBMs” and urges continued bipartisan work on this critical issue.
Plan reflects NACDS’ comments from 2019 as well as lessons and recommendations from the COVID-19 pandemic.
Dr. Adalja described the AMA’s position on COVID-19 antivirals as a “surefire path to ensuring that the window for timely treatment only opens a crack, at best.”
New law empowers pharmacists to optimize patient-centered care models, advance access to immunizations, essential medications and more.
On Wednesday, March 24, the Congressional Hispanic Caucus (CHC) COVID-19 task force met with NACDS member pharmacies.
At a virtual industry event, NACDS' president and CEO delivered "state of the industry" remarks hailing the role of pharmacy to address COVID-19 and to confront health disparities, and calling for pro-patient and pro-pharmacy public policy.